-
公开(公告)号:US5770567A
公开(公告)日:1998-06-23
申请号:US339517
申请日:1994-11-14
申请人: Wei-Hsien Ho , Phyllis L. Osheroff
发明人: Wei-Hsien Ho , Phyllis L. Osheroff
IPC分类号: G01N33/53 , A61K38/00 , A61P25/00 , C07K14/47 , C07K14/52 , C07K16/24 , C12N5/06 , C12N15/00 , C12N15/02 , C12N15/09 , C12N15/12 , C12P21/02 , C12P21/08 , C12R1/91 , A61K38/18 , C07K14/475
CPC分类号: C07K14/4705 , A61K38/00
摘要: Isolated SMDF, isolated DNA encoding SMDF, and recombinant or synthetic methods of preparing SMDF are disclosed. SMDF contains a .beta.-type EGF-like domain and a N-terminal sequence which is distinct from all neuregulins reported so far. SMDF, when expressed in recombinant cell culture, activates tyrosine phosphorylation of the HER2/neu receptor in human breast cancer cells and displays mitogenic activity on Schwann cells. Northern blot and in situ hybridization analysis show that SMDF differs from other neuregulins in that it is nervous tissue specific, and is very highly expressed, in comparison to other neuregulins, in the human and rat spinal cord motor neurons and sensory neurons.
摘要翻译: 公开了分离的SMDF,分离的编码SMDF的DNA,以及制备SMDF的重组或合成方法。 SMDF含有与目前报道的所有神经调节蛋白不同的β型EGF样结构域和N-末端序列。 当在重组细胞培养物中表达时,SMDF激活人乳腺癌细胞中HER2 / neu受体的酪氨酸磷酸化,并显示对施旺细胞的促有丝分裂活性。 Northern印迹和原位杂交分析显示,SMDF与其他神经调节蛋白不同之处在于其是神经组织特异性的,并且与人类和大鼠脊髓运动神经元和感觉神经元中的其他神经调节蛋白相比非常高度表达。
-
公开(公告)号:US5478807A
公开(公告)日:1995-12-26
申请号:US902637
申请日:1992-06-23
CPC分类号: C07K14/64 , A61K38/2221 , C07K14/72
摘要: The invention concerns the use of relaxin or another compound capable of specific binding of a relaxin receptor in the heart in the cardiovascular therapy, and specifically in the treatment of acute and chronic heart failure or of a condition characterized by pathologically low heart rate. The invention further concerns the treatment of neurodegenerative diseases using relaxin or other compounds capable of selectively binding a relaxin receptor in the brain.
摘要翻译: 本发明涉及在心血管治疗中使用松弛素或能够在心脏中特异性结合松弛素受体的另一种化合物,特别涉及治疗急性和慢性心力衰竭或病理学上低心率特征的病症。 本发明还涉及使用松弛素或能够选择性结合脑中的松弛素受体的其它化合物来治疗神经变性疾病。
-
公开(公告)号:US5166191A
公开(公告)日:1992-11-24
申请号:US747080
申请日:1991-08-19
CPC分类号: C07K14/64 , A61K38/2221 , C07K14/72
摘要: The invention concerns the use of relaxin in the cardiovascular therapy, and specifically in the treatment of acute and chronic heart failure.
摘要翻译: 本发明涉及松脂素在心血管治疗中的用途,特别涉及治疗急性和慢性心力衰竭。
-
公开(公告)号:US5763213A
公开(公告)日:1998-06-09
申请号:US428298
申请日:1995-04-25
申请人: Wei-Hsien Ho , Phyllis L. Osheroff
发明人: Wei-Hsien Ho , Phyllis L. Osheroff
IPC分类号: G01N33/53 , A61K38/00 , A61P25/00 , C07K14/47 , C07K14/52 , C07K16/24 , C12N5/06 , C12N15/00 , C12N15/02 , C12N15/09 , C12N15/12 , C12P21/02 , C12P21/08 , C12R1/91 , C07H21/04 , C12N15/63 , C12N15/85
CPC分类号: C07K14/4705 , A61K38/00
摘要: Isolated SMDF, isolated DNA encoding SMDF, and recombinant or synthetic methods of preparing SMDF are disclosed. SMDF contains a .beta.-type EGF-like domain and a N-terminal sequence which is distinct from all neuregulins reported so far. SMDF, when expressed in recombinant cell culture, activates tyrosine phosphorylation of the HER2/neu receptor in human breast cancer cells and displays mitogenic activity on Schwann cells. Northern blot and in situ hybridization analysis show that SMDF differs from other neuregulins in that it is nervous tissue specific, and is very highly expressed, in comparison to other neuregulins, in the human and rat spinal cord motor neurons and sensory neurons.
-
5.
公开(公告)号:US5756456A
公开(公告)日:1998-05-26
申请号:US428927
申请日:1995-04-25
申请人: Wei-Hsien Ho , Phyllis L. Osheroff
发明人: Wei-Hsien Ho , Phyllis L. Osheroff
IPC分类号: G01N33/53 , A61K38/00 , A61P25/00 , C07K14/47 , C07K14/52 , C07K16/24 , C12N5/06 , C12N15/00 , C12N15/02 , C12N15/09 , C12N15/12 , C12P21/02 , C12P21/08 , C12R1/91 , A61K38/18
CPC分类号: C07K14/4705 , A61K38/00
摘要: A method for activating the HER2 receptor comprising contacting a cell which expresses this receptor with SMDF polypeptides is discussed. A method for enhancing differentiation and/or proliferation of a cell using SMDF polypeptides is also disclosed. These methods may be performed in vitro or in vivo.
摘要翻译: 讨论了激活HER2受体的方法,包括使表达该受体的细胞与SMDF多肽接触。 还公开了使用SMDF多肽增强细胞分化和/或增殖的方法。 这些方法可以在体外或体内进行。
-
公开(公告)号:US5667780A
公开(公告)日:1997-09-16
申请号:US428926
申请日:1995-04-25
申请人: Wei-Hsien Ho , Phyllis L. Osheroff
发明人: Wei-Hsien Ho , Phyllis L. Osheroff
IPC分类号: G01N33/53 , A61K38/00 , A61P25/00 , C07K14/47 , C07K14/52 , C07K16/24 , C12N5/06 , C12N15/00 , C12N15/02 , C12N15/09 , C12N15/12 , C12P21/02 , C12P21/08 , C12R1/91 , C07K16/18 , A61K39/395 , C12N5/12
CPC分类号: C07K14/4705 , A61K38/00
摘要: Isolated SMDF, isolated DNA encoding SMDF, and antibodies to SMDF are disclosed. SMDF contains a .beta.-type EGF-like domain and a N-terminal sequence which is distinct from all neuregulins reported so far. SMDF, when expressed in recombinant cell culture, activates tyrosine phosphorylation of the HER2/neu receptor in human breast cancer cells and displays mitogenic activity on Schwann cells. Northern blot and in situ hybridization analysis show that SMDF differs from other neuregulins in that it is nervous tissue specific, and is very highly expressed, in comparison to other neuregulins, in the human and rat spinal cord motor neurons and sensory neurons.
摘要翻译: 公开了分离的SMDF,编码SMDF的分离的DNA和针对SMDF的抗体。 SMDF含有与目前报道的所有神经调节蛋白不同的β型EGF样结构域和N-末端序列。 当在重组细胞培养物中表达时,SMDF激活人乳腺癌细胞中HER2 / neu受体的酪氨酸磷酸化,并显示对施旺细胞的促有丝分裂活性。 Northern印迹和原位杂交分析显示,SMDF与其他神经调节蛋白不同之处在于其是神经组织特异性的,并且与人类和大鼠脊髓运动神经元和感觉神经元中的其他神经调节蛋白相比非常高度表达。
-
-
-
-
-